ZTE and Panasonic have both transferred small packages of patents to a relatively new US NPE called Global Innovation Aggregators, a Delaware registered entity with offices in Pasadena, California.
According to the assignment records Panasonic handed over 11 US grants in two separate deals that were recorded on the USPTO’s site earlier this month and executed in late February. Meanwhile Chinese tech giant ZTE disposed of seven US assets in a deal which was executed on 22nd January and recorded on 15th March. For Panasonic it is the latest in a long line of patent divestments which most recently included the transfer...
There is no more controversial subject in the US patent world right now than the inter partes review (IPR) regime. The patent death squad or the killer of bad patents, you decide. But one thing everyone can agree on, surely, is that IPRs have saved companies billions of dollars. By wiping out patents in whole or in part before they are litigated to the end, both sides get to save great chunks of cash, right?
Well, maybe not. IP Edge managing director Gautham Bodepudi has been doing some calculaitons and, he claims, while some parties do indeed make big savings, overall the...
How do you find perfect licensees for your patent-protected technologies? Word of mouth? Industry contacts? External consultancies? In a world full of work-enhancing technologies, there's got to be a better way. Join PatSnap's webinar to learn what data is available today to help you find the best licensees, how to find novel applications of technologies like yours, what tools are available to help you analyse licensing data and draw actionable insight from it to develop strategies, and more.
Litigation developments in Delhi over the last few months have put a spotlight on a somewhat unique feature of India’s patent system: Form 27, which requires patentees to disclose how they commercially exploit their granted rights. Now, it appears that the Patent Office will consider making changes to the form, which has long been controversial among multinational patent owners.
Each year, patentees must submit a disclosure to the Indian Patent Office stating whether each patent they own is being “worked” on a commercial scale in India. Among other things, the form asks for the “quantum and value” of patented products both manufactured...
In just over a year the United Kingdom will be leaving the European Union. According to those who fought for such an outcome during the 2016 referendum campaign, and have been responsible for implementing the result ever since as senior governmet ministers, once that happens a bright new dawn approaches.
The UK, we are told, will throw away the chains imposed by the bureaucrats in Brussels and once again bestride the globe, doing trade deals with a multitude of grateful nations and, apparently, selling products we have not been able to sell before into markets that have not been able to buy...
In late November 2017, the US Supreme Court heard arguments in Oil States Energy Servies v Greene’s Energy Group, undoubtedly one of the most consequential patent cases that it has heard in the last decade. Such has been the impact of the Patent Trial and Appeal Board (PTAB) on patent owning rights and litigation strategy, that for private practice lawyers, in-house IP counsel, other senior IP executives - and, of course, the administrative patent judges and senior staff of the USPTO - a ruling from the court that the inter partes review (IPR) process is unconstitutional would be huge.
Some of the...
Last week saw a further backlash against Allergan’s 2017 Saint Regis Mohawk deal, with the introduction of proposed legislation to eliminate sovereign immunity as grounds for exemption from cancellation hearings before the US Patent and Trademark Office (USPTO).
The tabling of the bill suggests that the pharma company’s effort to shield its patents from the inter partes review has been a political, as well as a legal, failure. And, while Allergan’s ploy was unique among life sciences innovators, it seems to have further inflamed wider controversies surrounding pharmaceuticals patents that currently looms large in American politics.
The Preserving Access to Cost Effective Drugs...
A quick glance at the list of attendees for today’s IPBC Southeast Asia event in Singapore confirms that major multinational technology companies are keenly interested in how this fast-growing part of the world is developing. In part, that is because many have extensive R&D and manufacturing operations in the region; but local firms are also increasingly seen as potential partners technology licence and transfer deals, as delegates heard today.
GE is one multinational that has made partnerships and technology transfer a major pillar of its IP strategy in recent times. In an IAM article last month, the president of GE Ventures’ licensing operation Pat...
Senior licensing executive Tanya Moore is leaving Sonos after little over a year at the audio business. Her departure comes as something of a surprise given that the company has continued to enjoy considerable success in its litigation against rival speaker manufacturer Denon and looked set to capitalise on its strong IP position in the rapidly evolving audio market.
Moore was hired in early 2017 as the company’s first chief licensing officer. With Sonos looking to sharpen its focus on IP value creation she was a direct report to CEO Patrick Spence. A well-known figure in the licensing community, she had...
There is not much time remaining to complete IAM’s annual IP benchmarking survey, which closes on 18th March. Those who do will be entered into a draw to win a complimentary delegate place at this year’s IPBC Global in San Francisco in June.
The survey should take no longer than 15 minutes to complete, and your participation will help us to shine a light on the issues currently facing the IP profession – whether relating to patent transactions and litigation, IP office performance or the political climate – and how these have changed year-on-year.
If you work for an IP-owning company, please click...
Read Full Article
Read for later
Articles marked as Favorite are saved for later viewing.
Scroll to Top
Separate tags by commas
To access this feature, please upgrade your account.